nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.046	0.109	CbGeAlD
Orphenadrine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.0244	0.0579	CbGeAlD
Orphenadrine—GRIN2D—forebrain—attention deficit hyperactivity disorder	0.0172	0.0408	CbGeAlD
Orphenadrine—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.0162	0.0384	CbGeAlD
Orphenadrine—GRIN1—forebrain—attention deficit hyperactivity disorder	0.0153	0.0364	CbGeAlD
Orphenadrine—SCN1A—forebrain—attention deficit hyperactivity disorder	0.0103	0.0245	CbGeAlD
Orphenadrine—GRIN1—midbrain—attention deficit hyperactivity disorder	0.0101	0.024	CbGeAlD
Orphenadrine—GRIN2D—nervous system—attention deficit hyperactivity disorder	0.00934	0.0222	CbGeAlD
Orphenadrine—SCN10A—forebrain—attention deficit hyperactivity disorder	0.00914	0.0217	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—attention deficit hyperactivity disorder	0.00899	0.0213	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—attention deficit hyperactivity disorder	0.00879	0.0208	CbGeAlD
Orphenadrine—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.00878	0.0208	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.00845	0.0201	CbGeAlD
Orphenadrine—GRIN1—nervous system—attention deficit hyperactivity disorder	0.00832	0.0197	CbGeAlD
Orphenadrine—GRIN1—central nervous system—attention deficit hyperactivity disorder	0.00801	0.019	CbGeAlD
Orphenadrine—SCN9A—midbrain—attention deficit hyperactivity disorder	0.00793	0.0188	CbGeAlD
Orphenadrine—GRIN1—cerebellum—attention deficit hyperactivity disorder	0.00783	0.0186	CbGeAlD
Orphenadrine—GRIN2D—brain—attention deficit hyperactivity disorder	0.00714	0.0169	CbGeAlD
Orphenadrine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00707	0.0168	CbGeAlD
Orphenadrine—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.00703	0.0167	CbGeAlD
Orphenadrine—SCN1A—midbrain—attention deficit hyperactivity disorder	0.00682	0.0162	CbGeAlD
Orphenadrine—GRIN3A—brain—attention deficit hyperactivity disorder	0.00671	0.0159	CbGeAlD
Orphenadrine—GRIN1—brain—attention deficit hyperactivity disorder	0.00636	0.0151	CbGeAlD
Orphenadrine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00598	0.0142	CbGeAlD
Orphenadrine—SCN4A—nervous system—attention deficit hyperactivity disorder	0.00582	0.0138	CbGeAlD
Orphenadrine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00569	0.0135	CbGeAlD
Orphenadrine—SCN1A—nervous system—attention deficit hyperactivity disorder	0.00561	0.0133	CbGeAlD
Orphenadrine—SCN4A—central nervous system—attention deficit hyperactivity disorder	0.0056	0.0133	CbGeAlD
Orphenadrine—SCN1A—central nervous system—attention deficit hyperactivity disorder	0.0054	0.0128	CbGeAlD
Orphenadrine—SCN1A—cerebellum—attention deficit hyperactivity disorder	0.00528	0.0125	CbGeAlD
Orphenadrine—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00511	0.0121	CbGeAlD
Orphenadrine—SCN9A—brain—attention deficit hyperactivity disorder	0.00498	0.0118	CbGeAlD
Orphenadrine—SCN10A—nervous system—attention deficit hyperactivity disorder	0.00496	0.0118	CbGeAlD
Orphenadrine—SCN10A—central nervous system—attention deficit hyperactivity disorder	0.00478	0.0113	CbGeAlD
Orphenadrine—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00451	0.0107	CbGeAlD
Orphenadrine—SCN4A—brain—attention deficit hyperactivity disorder	0.00445	0.0105	CbGeAlD
Orphenadrine—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00434	0.0103	CbGeAlD
Orphenadrine—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.00432	0.0103	CbGeAlD
Orphenadrine—SCN1A—brain—attention deficit hyperactivity disorder	0.00429	0.0102	CbGeAlD
Orphenadrine—HRH1—forebrain—attention deficit hyperactivity disorder	0.0041	0.00972	CbGeAlD
Orphenadrine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00384	0.00911	CbGeAlD
Orphenadrine—SCN10A—brain—attention deficit hyperactivity disorder	0.00379	0.009	CbGeAlD
Orphenadrine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.0037	0.00877	CbGeAlD
Orphenadrine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00355	0.00841	CbGeAlD
Orphenadrine—SCN5A—brain—attention deficit hyperactivity disorder	0.00345	0.00818	CbGeAlD
Orphenadrine—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00337	0.008	CbGeAlD
Orphenadrine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00333	0.00789	CbGeAlD
Orphenadrine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.00309	0.00733	CbGeAlD
Orphenadrine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.00297	0.00706	CbGeAlD
Orphenadrine—CHRM2—brain—attention deficit hyperactivity disorder	0.00294	0.00696	CbGeAlD
Orphenadrine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.00279	0.071	CrCbGaD
Orphenadrine—KCNH2—nervous system—attention deficit hyperactivity disorder	0.00277	0.00658	CbGeAlD
Orphenadrine—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.00267	0.00634	CbGeAlD
Orphenadrine—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.00261	0.00619	CbGeAlD
Orphenadrine—SLC6A2—brain—attention deficit hyperactivity disorder	0.00236	0.0056	CbGeAlD
Orphenadrine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00228	0.0054	CbGeAlD
Orphenadrine—HRH1—nervous system—attention deficit hyperactivity disorder	0.00222	0.00527	CbGeAlD
Orphenadrine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00219	0.0052	CbGeAlD
Orphenadrine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00218	0.0553	CrCbGaD
Orphenadrine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.00214	0.00508	CbGeAlD
Orphenadrine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00214	0.00507	CbGeAlD
Orphenadrine—KCNH2—brain—attention deficit hyperactivity disorder	0.00212	0.00503	CbGeAlD
Orphenadrine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00206	0.00488	CbGeAlD
Orphenadrine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00202	0.0512	CrCbGaD
Orphenadrine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00201	0.00477	CbGeAlD
Orphenadrine—Reboxetine—SLC6A4—attention deficit hyperactivity disorder	0.00183	0.0464	CrCbGaD
Orphenadrine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.00177	0.045	CrCbGaD
Orphenadrine—CYP2B6—brain—attention deficit hyperactivity disorder	0.00174	0.00413	CbGeAlD
Orphenadrine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00172	0.00408	CbGeAlD
Orphenadrine—HRH1—brain—attention deficit hyperactivity disorder	0.0017	0.00403	CbGeAlD
Orphenadrine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00165	0.00393	CbGeAlD
Orphenadrine—CYP2E1—brain—attention deficit hyperactivity disorder	0.00163	0.00387	CbGeAlD
Orphenadrine—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.00155	0.0393	CrCbGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00118	0.00219	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00117	0.00217	CbGpPWpGaD
Orphenadrine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.0298	CrCbGaD
Orphenadrine—GRIN2D—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00115	0.00214	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00115	0.00213	CbGpPWpGaD
Orphenadrine—Fluoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00115	0.0291	CrCbGaD
Orphenadrine—GRIN2D—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00114	0.00212	CbGpPWpGaD
Orphenadrine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00114	0.0291	CrCbGaD
Orphenadrine—KCNH2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00114	0.00211	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00112	0.00208	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00111	0.00206	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00111	0.00205	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00109	0.00203	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00109	0.00202	CbGpPWpGaD
Orphenadrine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00109	0.0277	CrCbGaD
Orphenadrine—SCN9A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00109	0.00202	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00109	0.00202	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00108	0.00201	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00108	0.002	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00107	0.00199	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00106	0.00197	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00196	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00196	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00105	0.00195	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.00195	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00105	0.00195	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00104	0.00193	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00186	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.001	0.00186	CbGpPWpGaD
Orphenadrine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000992	0.0252	CrCbGaD
Orphenadrine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000984	0.025	CrCbGaD
Orphenadrine—KCNH2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000976	0.00181	CbGpPWpGaD
Orphenadrine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000972	0.0247	CrCbGaD
Orphenadrine—GRIN1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000971	0.0018	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000968	0.0018	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000965	0.00179	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000965	0.00179	CbGpPWpGaD
Orphenadrine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000963	0.0245	CrCbGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000962	0.00178	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000951	0.00176	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000947	0.00176	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000932	0.00173	CbGpPWpGaD
Orphenadrine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.000929	0.0236	CrCbGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000928	0.00172	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000923	0.00171	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000921	0.00171	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000915	0.0017	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000913	0.00169	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000913	0.00169	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000908	0.00168	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000906	0.00168	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000887	0.00164	CbGpPWpGaD
Orphenadrine—Fluoxetine—HTR2A—attention deficit hyperactivity disorder	0.00088	0.0224	CrCbGaD
Orphenadrine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.000876	0.0223	CrCbGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000875	0.00162	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000863	0.0016	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000857	0.00159	CbGpPWpGaD
Orphenadrine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000855	0.0217	CrCbGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000827	0.00153	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000826	0.00153	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00082	0.00152	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000811	0.0015	CbGpPWpGaD
Orphenadrine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00081	0.0206	CrCbGaD
Orphenadrine—KCNH2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000809	0.0015	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000798	0.00148	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000795	0.00147	CbGpPWpGaD
Orphenadrine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000794	0.0202	CrCbGaD
Orphenadrine—GRIN1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000789	0.00146	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000782	0.00145	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000769	0.00143	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000769	0.00143	CbGpPWpGaD
Orphenadrine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000756	0.0192	CrCbGaD
Orphenadrine—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000742	0.00138	CbGpPWpGaD
Orphenadrine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000736	0.0187	CrCbGaD
Orphenadrine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000726	0.00135	CbGpPWpGaD
Orphenadrine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000723	0.0184	CrCbGaD
Orphenadrine—KCNH2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000688	0.00128	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000683	0.00127	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000682	0.00126	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000678	0.00126	CbGpPWpGaD
Orphenadrine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000672	0.0171	CrCbGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000663	0.00123	CbGpPWpGaD
Orphenadrine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00066	0.0168	CrCbGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000643	0.00119	CbGpPWpGaD
Orphenadrine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.000641	0.0163	CrCbGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000633	0.00117	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000618	0.00115	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.00113	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000605	0.00112	CbGpPWpGaD
Orphenadrine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.000605	0.0154	CrCbGaD
Orphenadrine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.000602	0.0153	CrCbGaD
Orphenadrine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.0006	0.0153	CrCbGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000596	0.00111	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000596	0.0011	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000594	0.0011	CbGpPWpGaD
Orphenadrine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.000585	0.0149	CrCbGaD
Orphenadrine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.00058	0.0147	CrCbGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000579	0.00107	CbGpPWpGaD
Orphenadrine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.000577	0.0147	CrCbGaD
Orphenadrine—Doxepin—DRD2—attention deficit hyperactivity disorder	0.000574	0.0146	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000566	0.0144	CrCbGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000564	0.00105	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000562	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000558	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000553	0.00103	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000551	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000542	0.00101	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000537	0.000995	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000527	0.000978	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000523	0.000969	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000521	0.000966	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000521	0.000966	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000514	0.000954	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000512	0.00095	CbGpPWpGaD
Orphenadrine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00051	0.013	CrCbGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000506	0.000939	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000498	0.000924	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000498	0.000923	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000491	0.000911	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00049	0.000908	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000485	0.0009	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000485	0.000899	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000483	0.000897	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000482	0.000893	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000474	0.000879	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000473	0.000877	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000472	0.000875	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00047	0.000871	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000468	0.000869	CbGpPWpGaD
Orphenadrine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.000465	0.0118	CrCbGaD
Orphenadrine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000465	0.000863	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000465	0.000862	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000462	0.000857	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000459	0.000851	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000458	0.000849	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000455	0.000845	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000452	0.000839	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00045	0.000835	CbGpPWpGaD
Orphenadrine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.000449	0.0114	CrCbGaD
Orphenadrine—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.000448	0.0114	CrCbGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000448	0.00083	CbGpPWpGaD
Orphenadrine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.000446	0.0113	CrCbGaD
Orphenadrine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000446	0.0113	CrCbGaD
Orphenadrine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.000444	0.0113	CrCbGaD
Orphenadrine—Doxepin—HTR2A—attention deficit hyperactivity disorder	0.000443	0.0113	CrCbGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000441	0.000817	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000434	0.000804	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000427	0.000791	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000426	0.000791	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000421	0.000781	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00042	0.000778	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.000778	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000415	0.000769	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000414	0.000768	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000413	0.000766	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000398	0.000738	CbGpPWpGaD
Orphenadrine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000394	0.01	CrCbGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000392	0.000727	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000386	0.000716	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000371	0.000688	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000367	0.00068	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000361	0.000669	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000349	0.000648	CbGpPWpGaD
Orphenadrine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.000345	0.00877	CrCbGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000344	0.000637	CbGpPWpGaD
Orphenadrine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.000343	0.00871	CrCbGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000342	0.000634	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000341	0.000632	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000337	0.000625	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000337	0.000624	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000335	0.000622	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00033	0.000612	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000325	0.000603	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000325	0.000602	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000321	0.000595	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000321	0.000595	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000592	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000317	0.000588	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000315	0.000585	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000315	0.000585	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000312	0.000579	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000311	0.000576	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000309	0.000574	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000306	0.000567	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000299	0.000554	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000294	0.000545	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000284	0.000527	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000279	0.000518	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000275	0.00051	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000275	0.000509	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000274	0.000508	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000274	0.000508	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00027	0.000501	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00025	0.000464	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000237	0.00044	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000233	0.000433	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000224	0.000416	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000218	0.000404	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000215	0.000399	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000215	0.000398	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000213	0.000395	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000212	0.000393	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000211	0.000392	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00021	0.000389	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000209	0.000388	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000207	0.000384	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000206	0.000382	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000204	0.000378	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000193	0.000357	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000193	0.000357	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000191	0.000355	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00019	0.000352	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000188	0.000349	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000188	0.000348	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000187	0.000347	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000187	0.000346	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000185	0.000343	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000184	0.000342	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000184	0.000341	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000184	0.00034	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000183	0.00034	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000181	0.000336	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000181	0.000335	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00018	0.000335	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00018	0.000334	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000178	0.000331	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000177	0.000328	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000175	0.000325	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000172	0.000319	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000169	0.000314	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000169	0.000313	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000167	0.000309	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000309	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000166	0.000308	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000165	0.000305	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.000304	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000162	0.0003	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000153	0.000284	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000151	0.00028	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000132	0.000245	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000132	0.000245	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00013	0.000241	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000129	0.00024	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000129	0.00024	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000127	0.000236	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000127	0.000236	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000125	0.000232	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000224	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000118	0.00022	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000118	0.000219	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000116	0.000216	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000111	0.000206	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000109	0.000203	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000107	0.000199	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000196	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000106	0.000196	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000103	0.000192	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000103	0.000192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000102	0.000189	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000187	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0001	0.000186	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.85e-05	0.000183	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.85e-05	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.84e-05	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.72e-05	0.00018	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.68e-05	0.00018	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.56e-05	0.000177	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.05e-05	0.000168	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.91e-05	0.000165	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.7e-05	0.000161	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	8.01e-05	0.000149	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.95e-05	0.000147	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	7.84e-05	0.000145	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.79e-05	0.000144	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.34e-05	0.000118	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.24e-05	0.000116	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.01e-05	0.000111	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.01e-05	0.000111	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.91e-05	0.00011	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.49e-05	0.000102	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.8e-05	8.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.57e-05	8.48e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.64e-05	6.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.61e-05	6.7e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.43e-05	6.37e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.36e-05	6.24e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.36e-05	6.23e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.31e-05	6.13e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.56e-05	2.89e-05	CbGpPWpGaD
